Subsequent Events	3 Months Ended
Jun. 30, 2025
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events Consummation of Sale of Substantially all Assets to Research Institute On July 14, 2025, the Company and Research Institute consummated the Research Institute Asset Purchase Agreement, whereby Research Institute acquired substantially all of the Debtors’ Assets, excluding the Excluded Assets, free and clear of liens, claims, encumbrances, and other interests other than certain permitted encumbrances, and assumed and paid the Liabilities. On the same date, the Company received sale proceeds of $302.5 million in cash. Research Institute continues to serve as a stalking horse sponsor of a Chapter 11 plan to acquire the Excluded Business for an aggregate purchase price of $2.5 million. The Excluded Assets consist primarily of the assets of the Excluded Business. The Chapter 11 Cases remain pending, and the Company expects to provide additional information regarding the distribution of proceeds from the Transaction, if any, at a subsequent date. Research Institute is an affiliate of Anne Wojcicki, the Company’s co-founder, former Chief Executive Officer, and current member of the Company’s Board of Directors. Accordingly, the Company determined that Research Institute is a related party. Repayment of DIP Financing Borrowings On July 14, 2025, in connection with the consummation of the Transaction, all outstanding indebtedness was paid in full and all commitments and obligations were terminated related to the DIP Financing with JMB. The Company repaid $25.0 million of borrowings and paid $0.1 million of interest, the Exit Fee of $2.4 million, and legal fees totaling $0.5 million. Payment of Break-Up Fee to Regeneron On June 6, 2025, the Bankruptcy Court authorized the Debtors to pay Regeneron a $10.0 million break-up fee concurrently with the closing of the Transaction with Research Institute if the Debtors selected Research Institute as the auction winner. On July 16, 2025, following the consummation of the Transaction, the Company paid the $10.0 million break-up fee to Regeneron. Settlement of AIP Annual Incentive Bonuses for Fiscal 2025 For the one-year performance period ended March 31, 2025, based upon the achievement of certain pre-established performance metrics and as determined by the Compensation Committee of the Company’s Board of Directors, the Company settled fiscal 2025 AIP payouts of approximately $3.6 million in cash on July 16, 2025. As of April 1, 2025, the AIP has been discontinued.

On July 14, 2025, the Company and Research Institute consummated the Research Institute Asset Purchase Agreement, whereby Research Institute acquired substantially all of the Debtors’ Assets, excluding the Excluded Assets, free and clear of liens, claims, encumbrances, and other interests other than certain permitted encumbrances, and assumed and paid the Liabilities. On the same date, the Company received sale proceeds of $302.5 million in cash. Research Institute continues to serve as a stalking horse sponsor of a Chapter 11 plan to acquire the Excluded Business for an aggregate purchase price of $2.5 million. The Excluded Assets consist primarily of the assets of the Excluded Business.

The Chapter 11 Cases remain pending, and the Company expects to provide additional information regarding the distribution of proceeds from the Transaction, if any, at a subsequent date.

Research Institute is an affiliate of Anne Wojcicki, the Company’s co-founder, former Chief Executive Officer, and current member of the Company’s Board of Directors. Accordingly, the Company determined that Research Institute is a related party.

On July 14, 2025, in connection with the consummation of the Transaction, all outstanding indebtedness was paid in full and all commitments and obligations were terminated related to the DIP Financing with JMB. The Company repaid $25.0 million of borrowings and paid $0.1 million of interest, the Exit Fee of $2.4 million, and legal fees totaling $0.5 million.

On June 6, 2025, the Bankruptcy Court authorized the Debtors to pay Regeneron a $10.0 million break-up fee concurrently with the closing of the Transaction with Research Institute if the Debtors selected Research Institute as the auction winner. On July 16, 2025, following the consummation of the Transaction, the Company paid the $10.0 million break-up fee to Regeneron.

For the one-year performance period ended March 31, 2025, based upon the achievement of certain pre-established performance metrics and as determined by the Compensation Committee of the Company’s Board of Directors, the Company settled fiscal 2025 AIP payouts of approximately $3.6 million in cash on July 16, 2025. As of April 1, 2025, the AIP has been discontinued.